K

Keros Therapeutics

Develops TGF-ß signaling-modulating therapeutics

Senior Medical Director

Biology & BiotechConfirmed live in the last 24 hours
Full-timeLexington, MA, USA$332k - $381k

About the Job

Requirements

  • An M.D., D.O., or equivalent medical degree is required.
  • Board eligibility or certification in Neurology, Pediatric Neurology, or a related field is desired.
  • Strong working knowledge of good clinical practice, clinical development pathways, and regulatory special designations is expected.
  • A minimum of 5 years of clinical drug development experience in the biopharmaceutical industry is required.
  • At least 3 years of clinical practice experience is preferred; completion of a subspecialty fellowship fulfills this requirement.
  • Direct experience with the roles and responsibilities of a trial medical lead is required, with a track record of successfully navigating complex clinical trials and global clinical development challenges.
  • Direct experience with pediatric and/or rare-indication clinical trials is desired; experience with neuromuscular clinical trials is preferred.
  • Exceptional medical and scientific knowledge of neuromuscular disorders is desired; a proven record of learning new indications along with scientific acumen and curiosity will also be considered.
  • Strategic and analytical thinking skills are necessary, including the ability to anticipate, prevent, and creatively solve complex drug development challenges.
  • Excellent verbal, written, and presentation communication skills are required.
  • Demonstrated leadership and the ability to influence without direct authority are necessary; candidates should provide examples of leadership influencing drug development decisions.
  • A high level of emotional intelligence and the ability to build collaborative, cross-functional relationships are essential.
  • Ability to work on-site in the Lexington, Massachusetts office at least 3 days a week is required.

Responsibilities

  • Lead clinical development strategy for rinvatercept, including development of the clinical development plan and design of future clinical trials, working within the cross-functional Program Team to ensure strategic alignment.
  • Contribute the clinical development perspective to program-level risk identification and mitigation, and offer creative solutions to identified problems.
  • Provide oversight and hands-on execution to ensure rinvatercept clinical development activities are delivered with up-front quality and within planned timelines.
  • Serve as the key advisor and author for relevant sections of regulatory submissions and associated documents, including queries and requests for information.
  • Represent Keros in face-to-face and written interactions with health authorities.
  • Participate in business development activities when requested by serving as the rinvatercept clinical development expert or evaluating in-licensing opportunities aligned with therapeutic-area expertise.
  • Provide medical leadership and expertise to cross-functional study teams, guiding the aligned execution of rinvatercept clinical trials in accordance with strategic goals.
  • Communicate trial progress, risks, and emerging data insights to internal teams and senior leadership, as appropriate.
  • Lead or supervise trial-related committees, such as a Safety Review Committee, Data Safety Monitoring Board, or Steering Committee, when appropriate for the trial design.
  • Provide oversight for authoring protocols, amendments, annual updates to the Investigator's Brochure, data publications, and final clinical study reports.
  • Lead advisory meetings with key opinion leaders to guide clinical development strategy and ensure study designs and clinical development plans reflect the evolving therapeutic-area landscape while balancing patient centricity and research needs.
  • Foster collaborative relationships with internal cross-functional stakeholders and represent the Program Team in delivering clinical development recommendations to senior leadership, when appropriate.

Desired Qualifications

  • Experience with Phase 3 design and biologics license application drafting is a plus.
  • A demonstrated ability to convey complex scientific information to varied audiences through presentations, publications, and teaching experience is desired.

About the Company

Keros Therapeutics

Develops TGF-ß signaling-modulating therapeutics

Keros Therapeutics focuses on developing therapies that target the transforming growth factor-beta (TGF-ß) signaling pathway to treat diseases linked to its dysfunction. Its products aim to modulate TGF-ß signaling to influence cellular growth and repair, with the goal of altering disease progression and providing disease-modifying benefits, especially in blood cells and tissues. The company advances therapeutics through research and development, with commercialization as its end goal once therapies are approved for patients. What sets Keros apart is its specialized expertise in TGF-ß biology and its emphasis on creating drugs that directly modulate this signaling network to produce meaningful clinical outcomes. The overall goal is to bring therapies to market that improve patient outcomes by correcting or adjusting TGF-ß-related signaling in relevant diseases.

Company size
51-200
Company stage
IPO
Headquarters
Lexington, KY
Founded
2015

Recently Posted Jobs

Explore more opportunities at Keros Therapeutics

See more jobs